Company Information

Company Orexo AB
Type:
SME
Country:
Sweden
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Publicly Listed
Global Compact Status:
Active
Participant Since
21 April 2017
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2025

Financial Information


Communication On Progress

Published On Title Level/Status
12-Jun-2024 2024 Communication on Progress Submitted
22-Dec-2023 2023 Communication on Progress Submitted
05-Apr-2022 Communication on Progress Orexo AB 2021 Active
30-Mar-2021 Communication on Progress Orexo AB Active
30-Mar-2020 Communication on Progress Active
20-Mar-2020 Reporting Cycle Adjustment Not applicable
25-Mar-2019 Sustainability Report 2018 (part of annual report) Active
27-Mar-2018 Orexo AB - Communication on Progress 2017 Active

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note: We can redact your name, signature and any other personal information from your CoP. However, in alignment with our standard procedure, please note that we do not delete the online profile of a former participant, nor its letters of commitment and/or any other documents (including CoPs) that have been submitted voluntarily by participants as part of their engagement with our initiative. Transparency and disclosure are core values to which participants adhere when joining the UN Global Compact, and we continue to uphold these values by ensuring a transparent record of our current and past participants on our public database. Please see our CoP Removal Request Policy for more information.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP , for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.